Natco Pharma (NSE:NATCOPHARM) Other Current Liabilities : ₹3,391 Mil (As of Mar. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Natco Pharma Other Current Liabilities?

Natco Pharma's other current liabilities for the quarter that ended in Mar. 2024 was ₹3,391 Mil.

Natco Pharma's quarterly other current liabilities declined from Sep. 2023 (₹2,036 Mil) to Dec. 2023 (₹0 Mil) but then increased from Dec. 2023 (₹0 Mil) to Mar. 2024 (₹3,391 Mil).

Natco Pharma's annual other current liabilities increased from Mar. 2022 (₹887 Mil) to Mar. 2023 (₹1,968 Mil) and increased from Mar. 2023 (₹1,968 Mil) to Mar. 2024 (₹3,391 Mil).

Natco Pharma Other Current Liabilities Historical Data

The historical data trend for Natco Pharma's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Natco Pharma Other Current Liabilities Chart

Natco Pharma Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Other Current Liabilities

Get a 7-Day Free Trial

Natco Pharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Current Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Natco Pharma Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Natco Pharma Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Natco Pharma's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Natco Pharma (NSE:NATCOPHARM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Natco Pharma Ltd (NSE:NATCOPHARM) » Definitions » Other Current Liabilities

Traded in Other Exchanges

524816:India

Address

Road No. 2, NATCO House, Banjara Hills, Hyderabad, TG, IND, 500034

Website

https://www.natcopharma.co.in

Natco Pharma Ltd is a major drug manufacturing company. Natco aims to make specialty medicines accessible to all by manufacturing niche pharmaceutical products backed by its research and development capabilities. While the vast majority of the company's revenue is generated in India, the company looks internationally for growth opportunities. The company maintains a presence in Oncology and Hepatology treatment areas. Natco's active pharmaceutical ingredient segment APIs forms a core part of the company's business. The company operates in two different business segments: pharmaceuticals and agrochemicals. Within the pharma business segment, the company drives its sales through Finished Dosage Forms and Active Pharmaceutical Ingredients.

Natco Pharma (NSE:NATCOPHARM) Headlines

No Headlines